Authors/Disclosures
|
Charles H. Adler, MD, PhD, FAAN
(Mayo Clinic Arizona)
|
Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care. |
|
Farhaan S. Vahidy, MBBS, PhD
(Houston Methodist)
|
Dr. Vahidy has nothing to disclose. |
|
|
No disclosure on file |
|
John N. Caviness, MD, FAAN
(Mayo Clinic)
|
Dr. Caviness has nothing to disclose. |
|
Robert W. Neel, MD
(University of Cincinnati Hospital)
|
Dr. Neel has nothing to disclose. |
|
John Donnelly
|
No disclosure on file |
|
Maria Giovanna Randisi, MD
(Ospedale Sant’Elia)
|
No disclosure on file |
|
Marwan N. Sabbagh, MD, FAAN
(Barrow Neurological Institute)
|
Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF. |
|
Louise D. McCullough, MD, PhD
(McGovern Medical School, UTHealth)
|
The institution of Dr. McCullough has received research support from NIH. The institution of Dr. McCullough has received research support from American Heart Association. |
|
Roberto Ugo Maria Grimaldi, MD
(Ospedale S.Elia - ASP 2- UOC Neurology)
|
No disclosure on file |
|
Donald J. Connor
(UCSD/ADRC)
|
No disclosure on file |
|
|
No disclosure on file |
|
Maria Grazia Naso
|
No disclosure on file |
|
Joseph Hentz
(Mayo Clinic)
|
No disclosure on file |
|
|
No disclosure on file |
|
Clorinda Occhipinti
(OSP. S. ELIA)
|
No disclosure on file |
|
Holly A. Shill, MD, FAAN
(Barrow Neurology Clinics)
|
Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. |
|
Sean I. Savitz, MD
|
Dr. Savitz has nothing to disclose. |
|
Josita Torrisi
|
No disclosure on file |
|
Virgilio Gerald H. Evidente, MD, FAAN
(Movement Disorders Center of Arizona)
|
Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. |
|
Karen C. Albright, DO, DO, PhD, MS, MPH
(FDA)
|
Dr. Albright has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Padma R. Mahant, MD
(Padma R. Mahant, MD LLC)
|
No disclosure on file |
|
Johan E. Samanta, MD
(Johan Samanta MD)
|
No disclosure on file |
|
Richard S. Burns, MD
|
No disclosure on file |
|
Erika Driver-Dunckley, MD, FAAN
|
Dr. Driver-Dunckley has nothing to disclose. |
|
Thomas Beach
(Banner Sun Health Research Institute)
|
Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona. |